Overview of therapeutic drug research for COVID-19 in China

Since the outbreak of novel coronavirus pneumonia (COVID-19) in December 2019, more than 2,500,000 people worldwide have been diagnosed with SARS-CoV-2 as of April 22. In response to this epidemic, China has issued seven trial versions of diagnosis and treatment protocol for COVID-19. According to t...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Heng, Yang, Li, Liu, Fei-fei, Ma, Xin-na, He, Pei-lan, Tang, Wei, Tong, Xian-kun, Zuo, Jian-ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298161/
https://www.ncbi.nlm.nih.gov/pubmed/32555446
http://dx.doi.org/10.1038/s41401-020-0438-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298161/
https://www.ncbi.nlm.nih.gov/pubmed/32555446
http://dx.doi.org/10.1038/s41401-020-0438-y

Ejemplares similares